| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/19/2012 | US20120014906 Organic compounds |
| 01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
| 01/19/2012 | US20120014876 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 01/19/2012 | US20120012123 Compositions, articles and methods for preventing or reducing tobacco-associated damage |
| 01/19/2012 | CA2805148A1 Novel fused heterocyclic derivatives useful as c-met tyrosine kinase inhibitors |
| 01/19/2012 | CA2804969A1 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 01/19/2012 | CA2804753A1 Anti-angiogenic agent and methods of using such agent |
| 01/19/2012 | CA2804744A1 Ip receptor agonist heterocyclic compounds |
| 01/19/2012 | CA2804640A1 Aldose reductase inhibitors and uses thereof |
| 01/19/2012 | CA2771928A1 Oxazine derivatives and their use in the treatment of neurological disorders |
| 01/18/2012 | EP2407536A1 ADP-ribosyl transferase fusion variant proteins |
| 01/18/2012 | EP2407478A1 New cyclotetrapeptides with pro-angiogenic properties |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2407466A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
| 01/18/2012 | EP2407174A1 Progression inhibitor or prophylactic agent for atherosclerosis, blood cholesterol level-lowering agent, and functional food or food for specified health uses |
| 01/18/2012 | EP2407168A1 Use of dpp iv inhibitors |
| 01/18/2012 | EP2407165A1 Antioxidant agent |
| 01/18/2012 | EP2406215A1 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 01/18/2012 | EP2405972A1 Use of rosuvastatin lactols as medicaments |
| 01/18/2012 | EP2405933A1 Method of treating heart failure |
| 01/18/2012 | EP2405930A1 Use of hasf as a protective agent against ischemic tissue damage |
| 01/18/2012 | EP2405921A1 Compositions and methods for silencing apolipoprotein c-iii expression |
| 01/18/2012 | EP2405911A1 Use of atorvastatin lactols as medicaments |
| 01/18/2012 | EP2405910A1 Rosuvastatin and atorvastatin derivatives |
| 01/18/2012 | EP2405772A1 Covalent milk protein/isothiocyanate complexes |
| 01/18/2012 | EP2405755A1 Methods and compositions for the treatment of metabolic and cardiovascular disorders |
| 01/18/2012 | EP2405747A1 Compositions and methods for treatment and prevention of cardiovascular disease |
| 01/18/2012 | EP2327413A9 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 01/18/2012 | EP1951738B1 Further crystalline forms of rostafuroxin |
| 01/18/2012 | EP1743940B1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/18/2012 | EP1637539B1 Pyrazole derivative, drug composition containing the same and production intermediate therefor |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | EP1256574B1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 01/18/2012 | CN102325550A Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature |
| 01/18/2012 | CN102325528A Activated blood coagulation factor X (FXa) inhibitor |
| 01/18/2012 | CN102321626A Means for inhibiting the expression of protein kinase 3 |
| 01/18/2012 | CN102321573A Tangential flow filtration devices and methods for stem cell enrichment |
| 01/18/2012 | CN102321239A Preparation method of water-soluble toluylene compound prodrugs |
| 01/18/2012 | CN102321134A Compound, preparation method and application |
| 01/18/2012 | CN102321129A Stilbene glycoside injection and preparation process thereof |
| 01/18/2012 | CN102321024A Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 01/18/2012 | CN102321023A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 01/18/2012 | CN102321020A LXR receptor modulators |
| 01/18/2012 | CN102320956A Sodium ferulate composition freeze-dried powder injection and preparation method thereof |
| 01/18/2012 | CN102319438A Genistein clathrate compound-containing preparation and its preparation method and use |
| 01/18/2012 | CN102319432A Ocular implant made by a double extrusion process |
| 01/18/2012 | CN102319429A Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 01/18/2012 | CN102319421A Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 01/18/2012 | CN102319401A Traditional Chinese medicine composition for tonifying qi and invigorating blood circulation, invigorating spleen and dredging collaterals and preparation method thereof |
| 01/18/2012 | CN102319399A Traditional Chinese medicine composition used for treating coronary heart disease and cerebral arteriosclerosis, and preparation method thereof |
| 01/18/2012 | CN102319394A Xingnaojing composition for injection and preparation method thereof |
| 01/18/2012 | CN102319381A Chinese medicinal composition for treating primary hypertension |
| 01/18/2012 | CN102319368A Chinese medicinal composition for treating hypertension and preparation method thereof |
| 01/18/2012 | CN102319364A Manufacturing method of dendrobium candidum wallex lindll pure powder tablets |
| 01/18/2012 | CN102319363A Hemorrhoid-pain ointment and preparation method thereof |
| 01/18/2012 | CN102319359A Traditional Chinese medicine preparation used for treating qi-yin asthenia disease |
| 01/18/2012 | CN102319352A Chinese medicinal formula for treating heart disease |
| 01/18/2012 | CN102319346A Oral liquid for treating hypertension |
| 01/18/2012 | CN102319331A Medicine for removing necrotic tissue and promoting granulation |
| 01/18/2012 | CN102319307A Preparation method of Baoxin tablet |
| 01/18/2012 | CN102319302A Total paeony glucoside self-microemulsifying soft capsules and preparation method thereof |
| 01/18/2012 | CN102319301A Total peony glycoside osmotic pump controlled release tablet and preparation method thereof |
| 01/18/2012 | CN102319300A Method for extracting total saponins from beesia calthaefolia medicinal material |
| 01/18/2012 | CN102319282A Aqueous two-phase extraction method for total flavones in kudzu root |
| 01/18/2012 | CN102319278A Monascus compound preparation capable of regulating pressure and lipid and improving arteriosclerosis, coronary heart disease and cerebral embolism |
| 01/18/2012 | CN102319277A Method for preparing fumaria capreolata L. total alkaloid extract |
| 01/18/2012 | CN102319268A Injection used for treating chronic congestive cardiac failure, and preparation method thereof |
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319252A Amlodipine and fosinopril sodium medical composition and preparation method thereof |
| 01/18/2012 | CN102319251A Aspirin and dipyridamole gastric floating capsule and preparation method thereof |
| 01/18/2012 | CN102319250A Irbesartan and hydrochlorothiazide medicinal composition and preparation method thereof |
| 01/18/2012 | CN102319239A Application of ainsliaidimer A in preparing nucleolus transcription factor inhibitor medicament |
| 01/18/2012 | CN102319233A Application of pterostilbene in inhibiting vascular endothelial apoptosis |
| 01/18/2012 | CN102319225A Trimetazidine hydrochloride sustained release tablet and preparation method thereof |
| 01/18/2012 | CN102319213A Beraprost acid nanolipid microsphere preparation |
| 01/18/2012 | CN102319212A Clevidipine butyrate structured lipid emulsion and preparation method thereof |
| 01/18/2012 | CN102319192A Enzyme bathing material for clearing toxins of human body and preparation method thereof |
| 01/18/2012 | CN102318989A Pillow capable of lowering blood pressure |
| 01/18/2012 | CN102000196B Chinese medicine composition for treating anal fistula |
| 01/18/2012 | CN101926868B External traditional Chinese medicine for preventing and treating phlebitis caused by chemotherapeutic medicines |
| 01/18/2012 | CN101891834B Polysaccharide sulfate fragment (PSC), preparation method and application thereof |
| 01/18/2012 | CN101884673B Piles ointment and preparation method thereof |
| 01/18/2012 | CN101874871B Medicine combination for promoting blood circulation and supplementing qi and nourishing yin and preparation method thereof |
| 01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
| 01/18/2012 | CN101613317B Mozavaptan synthesis technology for treating congestive heart failure (CHF) |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101514355B Method for preparing wheat germ protein ACE inhibitory peptide by continuous enzymolysis and ultra-filtration separation coupling |
| 01/18/2012 | CN101491670B Method for treating cardiovascular disease using nervous regulation protein and composite |
| 01/18/2012 | CN101406478B Pharmaceutical composition for reducing homosysteine |
| 01/18/2012 | CN101406466B Cinnamic acid transdermal patch and preparation technique thereof |
| 01/18/2012 | CN101390871B Ginsenoside Rb1 containing impurity ginsenoside Rd |
| 01/18/2012 | CN101304969B Benzene derivative or salt thereof |
| 01/17/2012 | US8097642 Therapeutic inhibitor of vascular smooth muscle cells |
| 01/17/2012 | US8097621 Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitors |
| 01/17/2012 | US8097617 Organic compounds |
| 01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
| 01/17/2012 | US8097585 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
| 01/17/2012 | CA2602290C Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1 ,4- benzoquinone for the treatment of muscular dystrophies |
| 01/17/2012 | CA2558139C Tricyclic benzopyran compound as anti-arrhythmic agents |
| 01/17/2012 | CA2500873C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |